EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Systematic Review and Meta-Analysis of Randomized Clinical Trials of Anti-Inflammatory Agents in Early-Stage Psychotic Disorders

Edward R Palmer, Matthew J Taylor, James E Hotham, David Salam, Ghayath Alshawaf, Jack C Rogers, Rachel Upthegrove

Schizophrenia Bulletin · 20.08.2026 · 52 (5)

DOI: 10.1093/schbul/sbaf173 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Schizophrenia Bulletin, online erschienen am 28.10.2025. Verfasst von Edward R Palmer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Mental Health, School of Psychology, University of Birmingham, Birmingham, B15 2TT, United Kingdom. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Outcome Assessment, Health Care, Psychotic Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Mental Health Translational Research Collaboration, NIHR Oxford Health Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Accumulating evidence suggests that immune dysregulation is present in psychosis, however, evidence for anti-inflammatory treatments is mixed. This may be because studies need to focus on when inflammation offers a modifiable target. This review and meta-analysis sought to clarify the effects of anti-inflammatory agents from high-quality randomized trials in patients at clinical high risk for psychosis (CHR) and first-episode of psychosis (FEP). Study Design Databases were searched until January 2025 for double-blind, randomized, placebo-controlled trials evaluating the effect of anti-inflammatory treatment compared with placebo in CHR and FEP populations. Primary outcomes were transition rates to psychosis in CHR and changes in total psychotic symptoms in FEP. Secondary outcomes included changes in symptoms in CHR and changes in symptom sub-scores in FEP. Study Results Searches retrieved 2168 articles, with 17 meeting inclusion criteria (5 for CHR, 12 for FEP). In CHR, anti-inflammatory treatment was not associated with a significant reduction in transition to psychosis (odds ratio 0.88, 95% CI, 0.26-3.01, P = .80). In FEP, anti-inflammatory treatment demonstrated a significant reduction in total psychotic symptoms; (standardized mean differences = −0.38, 95% CI, −0.76 to 0.00, P = .05). Secondary outcomes showed no change in symptoms in CHR, and significant changes in Positive and Negative Syndrome Scale positive sub-scores in FEP. Conclusions Adjuvant anti-inflammatory treatment may be efficacious in FEP. However, high heterogeneity was present across studies, with possible publication bias and small-study effects. We highlight the need for further, large, stage-specific trials to conclusively understand the potential therapeutic benefit of anti-inflammatory treatments in early psychosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory AgentsOutcome Assessment, Health CarePsychotic DisordersHumansRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

anti-inflammatory treatmentclinical high riskearly psychosisfirst-episode psychosis

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Institute for Mental Health, School of Psychology, University of Birmingham, Birmingham, B15 2TT, United Kingdom.
  • Early Intervention Service, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, B1 3RB, United Kingdom.
  • Mental Health Research Unit, Sheffield Centre for Health and Related Research, The University of Sheffield, Sheffield, S1 4DA, United Kingdom.
  • Sheffield Health and Social Care NHS Foundation Trust, Sheffield, S4 7QQ, United Kingdom.
  • Herefordshire and Worcestershire Health and Care NHS Trust, Worcester, WR5 1JR, United Kingdom.
  • Birmingham and Solihull Mental Health NHS Trust, Birmingham, B1 3RB, United Kingdom.

Förderung

  • National Institute for Health and Care Research
  • Mental Health Translational Research Collaboration
  • NIHR Oxford Health Biomedical Research Centre

Zitieren

APA

Palmer, E. R., Taylor, M. J., Hotham, J. E., Salam, D., Alshawaf, G., Rogers, J. C., & Upthegrove, R. (2026). Systematic Review and Meta-Analysis of Randomized Clinical Trials of Anti-Inflammatory Agents in Early-Stage Psychotic Disorders. Schizophrenia Bulletin, 52(5). https://doi.org/10.1093/schbul/sbaf173

Vancouver

Palmer ER, Taylor MJ, Hotham JE, Salam D, Alshawaf G, Rogers JC, et al. Systematic Review and Meta-Analysis of Randomized Clinical Trials of Anti-Inflammatory Agents in Early-Stage Psychotic Disorders. Schizophrenia Bulletin. 2026;52(5). doi:10.1093/schbul/sbaf173

BibTeX
@article{Palmer2026,
  author = {Palmer, Edward R and Taylor, Matthew J and Hotham, James E and Salam, David and Alshawaf, Ghayath and Rogers, Jack C and Upthegrove, Rachel},
  title = {Systematic Review and Meta-Analysis of Randomized Clinical Trials of Anti-Inflammatory Agents in Early-Stage Psychotic Disorders},
  journal = {Schizophrenia Bulletin},
  year = {2026},
  volume = {52},
  number = {5},
  doi = {10.1093/schbul/sbaf173}
}
Kostenlos starten →